table of content
1 Study Coverage
1.1 Next Generation Cancer Diagnostic Devices Product Introduction
1.2 Global Next Generation Cancer Diagnostic Devices Outlook 2017 VS 2022 VS 2028
1.2.1 Global Next Generation Cancer Diagnostic Devices Sales in US$ Million for the Year 2017-2028
1.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume for the Year 2017-2028
1.3 United States Next Generation Cancer Diagnostic Devices Outlook 2017 VS 2022 VS 2028
1.3.1 United States Next Generation Cancer Diagnostic Devices Sales in US$ Million for the Year 2017-2028
1.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume for the Year 2017-2028
1.4 Next Generation Cancer Diagnostic Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Next Generation Cancer Diagnostic Devices in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Next Generation Cancer Diagnostic Devices Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Next Generation Cancer Diagnostic Devices Market Dynamics
1.5.1 Next Generation Cancer Diagnostic Devices Industry Trends
1.5.2 Next Generation Cancer Diagnostic Devices Market Drivers
1.5.3 Next Generation Cancer Diagnostic Devices Market Challenges
1.5.4 Next Generation Cancer Diagnostic Devices Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Next Generation Cancer Diagnostic Devices Market Segment by Type
2.1.1 Next Generation Sequencing
2.1.2 qPCR & Multiplexing
2.1.3 Lab-on- a- chip (LOAC)
2.1.4 Protein Microarrays
2.1.5 DNA Microarrays
2.1.6 Reverse Transcriptase-PCR (RT-PCR)
2.2 Global Next Generation Cancer Diagnostic Devices Market Size by Type
2.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Next Generation Cancer Diagnostic Devices Market Size by Type
2.3.1 United States Next Generation Cancer Diagnostic Devices Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Next Generation Cancer Diagnostic Devices Market Segment by Application
3.1.1 Biomarker Development
3.1.2 CTC Analysis
3.1.3 Proteomic Analysis
3.1.4 Epigenetic Analysis
3.1.5 Genetic Analysis
3.2 Global Next Generation Cancer Diagnostic Devices Market Size by Application
3.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Next Generation Cancer Diagnostic Devices Market Size by Application
3.3.1 United States Next Generation Cancer Diagnostic Devices Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Next Generation Cancer Diagnostic Devices Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Next Generation Cancer Diagnostic Devices Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Next Generation Cancer Diagnostic Devices Competitor Landscape by Company
4.1 Global Next Generation Cancer Diagnostic Devices Market Size by Company
4.1.1 Top Global Next Generation Cancer Diagnostic Devices Manufacturers Ranked by Revenue (2021)
4.1.2 Global Next Generation Cancer Diagnostic Devices Revenue by Manufacturer (2017-2022)
4.1.3 Global Next Generation Cancer Diagnostic Devices Sales by Manufacturer (2017-2022)
4.1.4 Global Next Generation Cancer Diagnostic Devices Price by Manufacturer (2017-2022)
4.2 Global Next Generation Cancer Diagnostic Devices Concentration Ratio (CR)
4.2.1 Next Generation Cancer Diagnostic Devices Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Next Generation Cancer Diagnostic Devices in 2021
4.2.3 Global Next Generation Cancer Diagnostic Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Next Generation Cancer Diagnostic Devices Manufacturing Base Distribution, Product Type
4.3.1 Global Next Generation Cancer Diagnostic Devices Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Next Generation Cancer Diagnostic Devices Product Type
4.3.3 Date of International Manufacturers Enter into Next Generation Cancer Diagnostic Devices Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Next Generation Cancer Diagnostic Devices Market Size by Company
4.5.1 Top Next Generation Cancer Diagnostic Devices Players in United States, Ranked by Revenue (2021)
4.5.2 United States Next Generation Cancer Diagnostic Devices Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Next Generation Cancer Diagnostic Devices Sales by Players (2020, 2021 & 2022)
5 Global Next Generation Cancer Diagnostic Devices Market Size by Region
5.1 Global Next Generation Cancer Diagnostic Devices Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Next Generation Cancer Diagnostic Devices Market Size in Volume by Region (2017-2028)
5.2.1 Global Next Generation Cancer Diagnostic Devices Sales in Volume by Region: 2017-2022
5.2.2 Global Next Generation Cancer Diagnostic Devices Sales in Volume Forecast by Region (2023-2028)
5.3 Global Next Generation Cancer Diagnostic Devices Market Size in Value by Region (2017-2028)
5.3.1 Global Next Generation Cancer Diagnostic Devices Sales in Value by Region: 2017-2022
5.3.2 Global Next Generation Cancer Diagnostic Devices Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.1.2 North America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Next Generation Cancer Diagnostic Devices Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.3.2 Europe Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.4.2 Latin America Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Next Generation Cancer Diagnostic Devices Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Roche Holding Ltd.?Switzerland)
7.1.1 Roche Holding Ltd.?Switzerland) Corporation Information
7.1.2 Roche Holding Ltd.?Switzerland) Description and Business Overview
7.1.3 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Roche Holding Ltd.?Switzerland) Next Generation Cancer Diagnostic Devices Products Offered
7.1.5 Roche Holding Ltd.?Switzerland) Recent Development
7.2 Abbott Laboratories(US)
7.2.1 Abbott Laboratories(US) Corporation Information
7.2.2 Abbott Laboratories(US) Description and Business Overview
7.2.3 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Abbott Laboratories(US) Next Generation Cancer Diagnostic Devices Products Offered
7.2.5 Abbott Laboratories(US) Recent Development
7.3 Siemens Healthcare(Germany)
7.3.1 Siemens Healthcare(Germany) Corporation Information
7.3.2 Siemens Healthcare(Germany) Description and Business Overview
7.3.3 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Siemens Healthcare(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.3.5 Siemens Healthcare(Germany) Recent Development
7.4 Agilent Technologies Inc(Germany)
7.4.1 Agilent Technologies Inc(Germany) Corporation Information
7.4.2 Agilent Technologies Inc(Germany) Description and Business Overview
7.4.3 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Agilent Technologies Inc(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.4.5 Agilent Technologies Inc(Germany) Recent Development
7.5 Illumina Inc.(US)
7.5.1 Illumina Inc.(US) Corporation Information
7.5.2 Illumina Inc.(US) Description and Business Overview
7.5.3 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Illumina Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.5.5 Illumina Inc.(US) Recent Development
7.6 Becton Dickinson and Co.(US)
7.6.1 Becton Dickinson and Co.(US) Corporation Information
7.6.2 Becton Dickinson and Co.(US) Description and Business Overview
7.6.3 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Becton Dickinson and Co.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.6.5 Becton Dickinson and Co.(US) Recent Development
7.7 QIAGEN N.V.(Germany)
7.7.1 QIAGEN N.V.(Germany) Corporation Information
7.7.2 QIAGEN N.V.(Germany) Description and Business Overview
7.7.3 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.7.4 QIAGEN N.V.(Germany) Next Generation Cancer Diagnostic Devices Products Offered
7.7.5 QIAGEN N.V.(Germany) Recent Development
7.8 Affymetrix Inc.(US)
7.8.1 Affymetrix Inc.(US) Corporation Information
7.8.2 Affymetrix Inc.(US) Description and Business Overview
7.8.3 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Affymetrix Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.8.5 Affymetrix Inc.(US) Recent Development
7.9 Johnson & Johnson(US)
7.9.1 Johnson & Johnson(US) Corporation Information
7.9.2 Johnson & Johnson(US) Description and Business Overview
7.9.3 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Johnson & Johnson(US) Next Generation Cancer Diagnostic Devices Products Offered
7.9.5 Johnson & Johnson(US) Recent Development
7.10 Thermo Fisher Scientific Inc.(US)
7.10.1 Thermo Fisher Scientific Inc.(US) Corporation Information
7.10.2 Thermo Fisher Scientific Inc.(US) Description and Business Overview
7.10.3 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Thermo Fisher Scientific Inc.(US) Next Generation Cancer Diagnostic Devices Products Offered
7.10.5 Thermo Fisher Scientific Inc.(US) Recent Development
7.11 GE Healthcare(England)
7.11.1 GE Healthcare(England) Corporation Information
7.11.2 GE Healthcare(England) Description and Business Overview
7.11.3 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GE Healthcare(England) Next Generation Cancer Diagnostic Devices Products Offered
7.11.5 GE Healthcare(England) Recent Development
7.12 Life Technologies Corp.(US)
7.12.1 Life Technologies Corp.(US) Corporation Information
7.12.2 Life Technologies Corp.(US) Description and Business Overview
7.12.3 Life Technologies Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Life Technologies Corp.(US) Products Offered
7.12.5 Life Technologies Corp.(US) Recent Development
7.13 Luminex Corp.(US)
7.13.1 Luminex Corp.(US) Corporation Information
7.13.2 Luminex Corp.(US) Description and Business Overview
7.13.3 Luminex Corp.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Luminex Corp.(US) Products Offered
7.13.5 Luminex Corp.(US) Recent Development
7.14 Cepheid Inc.(US)
7.14.1 Cepheid Inc.(US) Corporation Information
7.14.2 Cepheid Inc.(US) Description and Business Overview
7.14.3 Cepheid Inc.(US) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Cepheid Inc.(US) Products Offered
7.14.5 Cepheid Inc.(US) Recent Development
7.15 Allegro Diagnostics Corp.(Brazil)
7.15.1 Allegro Diagnostics Corp.(Brazil) Corporation Information
7.15.2 Allegro Diagnostics Corp.(Brazil) Description and Business Overview
7.15.3 Allegro Diagnostics Corp.(Brazil) Next Generation Cancer Diagnostic Devices Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Allegro Diagnostics Corp.(Brazil) Products Offered
7.15.5 Allegro Diagnostics Corp.(Brazil) Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Next Generation Cancer Diagnostic Devices Industry Chain Analysis
8.2 Next Generation Cancer Diagnostic Devices Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Next Generation Cancer Diagnostic Devices Distributors
8.3 Next Generation Cancer Diagnostic Devices Production Mode & Process
8.4 Next Generation Cancer Diagnostic Devices Sales and Marketing
8.4.1 Next Generation Cancer Diagnostic Devices Sales Channels
8.4.2 Next Generation Cancer Diagnostic Devices Distributors
8.5 Next Generation Cancer Diagnostic Devices Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
